Personalized treatment of patients with rheumatoid arthritis depending on the T-786С eNOS gene promoter polymorphism and concomitant pathology

Bukach, O.; Pronina, A.; Dariy, Y.; Yarovyk, D.; Vachil, P.

dc.contributor.author	Bukach, O.
dc.contributor.author	Pronina, A.
dc.contributor.author	Dariy, Y.
dc.contributor.author	Yarovyk, D.
dc.contributor.author	Vachil, P.
dc.date.accessioned	2025-02-21T13:01:32Z
dc.date.available	2025-02-21T13:01:32Z
dc.date.issued	2023
dc.identifier.other	DOI: 10.5281/zenodo.8266139
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26215
dc.description.abstract	Purpose: optimization of rheumatoid arthritis treatment depending on the T-786C polymorphism of the eNOS gene promoter and comorbid pathology. Conclusions. Therefore, after the treatment, a decrease in the level of acute-phase indicators of inflammation was observed in all polymorphic variants of the T-786C eNOS gene, but it was the most significant in carriers of the TT genotype.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Znanstvena misel journal	uk_UA
dc.subject	rheumatoid arthritis	uk_UA
dc.subject	personalized treatment	uk_UA
dc.subject	eNOS gene promoter T-786C polymorphism	uk_UA
dc.subject	arterial hypertension	uk_UA
dc.subject	type 2 diabetes	uk_UA
dc.subject	abdominal obesity	uk_UA
dc.title	Personalized treatment of patients with rheumatoid arthritis depending on the T-786С eNOS gene promoter polymorphism and concomitant pathology	uk_UA
dc.type	Article	uk_UA